Finance

Beta
Lists
NVLG:TLV
Novolog Pharm Up 1966 Ltd
ILA 91,20
+3,40%
(+3,00) 1D
29 Mei, 13:44:32 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NVLG...
Open
ILA 88,20
High
ILA 95,30
Low
ILA 89,10
Mkt. cap
465,92 m
Avg. vol.
305,64 k
Volume
34,86 k
Dividend
5,37%
Quarterly dividend
ILA 1,22
Ex-dividend date
01 Des. 2025
P/E ratio
150,25
52-wk high
ILA 157,00
52-wk low
ILA 82,70
EPS
ILA 0,01
Shares outstanding
510,87 m
No. of employees
916
Open
ILA 88,20
High
ILA 95,30
Low
ILA 89,10
Mkt. cap
465,92 m
Avg. vol.
305,64 k
Volume
34,86 k
Dividend
5,37%
Quarterly dividend
ILA 1,22
Ex-dividend date
01 Des. 2025
P/E ratio
150,25
52-wk high
ILA 157,00
52-wk low
ILA 82,70
EPS
ILA 0,01
Shares outstanding
510,87 m
No. of employees
916
News stories
From sources across the web
About Novolog Pharm Up 1966 Ltd
CEOAviad Bussi
Employees916
Founded1966
Headquarters-
SectorHealth care provider
Websitenovolog.co.il
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
441,69 m
483,58 m
373,25 m
505,83 m
Cost of goods sold
404,36 m
447,35 m
306,78 m
474,69 m
Cost of revenue
404,36 m
447,35 m
306,78 m
474,69 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,81 m
26,35 m
31,08 m
26,07 m
Operating expense
17,85 m
26,92 m
29,91 m
26,05 m
Total operating expenses
422,21 m
474,27 m
336,70 m
500,75 m
Operating income
19,48 m
9,31 m
36,55 m
5,08 m
Other non operating income
-
-
-
862,00 k
EBT including unusual items
5,25 m
6,42 m
-6,85 m
-608,00 k
EBT excluding unusual items
14,25 m
5,52 m
29,77 m
-608,00 k
Income tax expense
597,00 k
2,16 m
-1,23 m
-796,00 k
Effective tax rate
11,37%
33,59%
17,99%
130,92%
Other operating expenses
-10,96 m
567,00 k
-1,17 m
-19,00 k
Net income
4,78 m
3,95 m
-5,63 m
442,00 k
Net profit margin
1,08%
0,82%
-1,51%
0,09%
Earnings per share
-
-
-
-
Interest and investment income
804,00 k
1,53 m
902,00 k
-
Interest expense
-6,08 m
-5,68 m
-3,57 m
-6,69 m
Net interest expenses
-5,27 m
-4,15 m
-2,67 m
-6,69 m
Depreciation and amortization charges
-
-
-
-
EBITDA
36,86 m
19,91 m
44,43 m
23,09 m
Gain or loss from assets sale
-54,00 k
-
-8,00 k
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer